Algorithm predicts females have higher risk for kidney damage after aneurysm repair

When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study finds. Researchers from Michigan Medicine designed an algorithm that can be used prior to endovascular AAA…
Five-year outcomes of ESAR in patients with short neck

Cohort analysis shows no migrations, a low rate of ruptures, and positive sac regression, researchers say. Five-year outcomes in patients with short neck abdominal aortic aneurysms (AAAs) undergoing endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchors with an Endurant stent-graft in…
The top 10 most popular Vascular Specialist stories of January 2023

In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate the benefits of vascular involvement in non-vascular-led cases; an update on the use of the Human Acellular…
SVS Foundation board approves latest pilot programs to help underserved

The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the Vascular Care for the Underserved program—the initiative formerly known as VISTA (Vascular Volunteers In Service To…
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage of SVS priorities’

Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory University in Atlanta—offered observations on the National Institutes of Health’s (NIH) “modestly” aligned vascular surgical funding…
Viz.ai launches AI-powered Viz Vascular Suite

Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary embolism, right heart strain, aortic dissection, and abdominal aortic aneurysm (AAA). The company submitted a new 510(k)…
Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of EVAR

Medtronic has announced the first patient enrollment in the ADVANCE trial, a head-to-head randomized controlled trial of two leading aortic stent graft systems, the Medtronic Endurant II/IIs stent graft system and Gore Excluder abdominal aortic aneurysm (AAA) device family systems.…
ESVS AAA guidelines alert recommends ‘enhanced surveillance’ in patients treated with Nellix device

In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines writing committee has published advice on the surveillance and management of patients treated with the Nellix endovascular aneurysm…
How a multidisciplinary team meets the complex challenges of fixing failed EVARs

This advertorial is sponsored by Tampa General Hospital. The Aortic Disease Program at Tampa General Hospital’s Heart & Vascular Institute is no stranger to the challenges of complex care. Situated in the population center of Tampa, Florida, in the nation’s…
Endologix receives FDA approval of PMA supplement for AFX2 system

Endologix recently announced that it has received Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system. According to a company press release, Endologix received approval to include an updated warning and the…

